Trials / Conditions / Neonatal Onset Multisystem Inflammatory Disease
Neonatal Onset Multisystem Inflammatory Disease
4 registered clinical trials studyying Neonatal Onset Multisystem Inflammatory Disease.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Peri NCT01576367 | Novartis Pharmaceuticals | Phase 3 |
| Completed | Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Peri NCT01302860 | Novartis Pharmaceuticals | Phase 3 |
| Completed | Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopy NCT00991146 | Novartis Pharmaceuticals | Phase 3 |
| Completed | Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial NCT00685373 | Novartis | Phase 3 |